“This is part of our effort across the Agency to deploy and keep up with the fast pace of technological change and to lower barriers to our innovation ecosystem.” – Kathi Vidal, USPTO The U.S. Patent ...

Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...

On November 7, 2023, the Federal Trade Commission (FTC) officially challenged more than 100 patents that brand name drug manufacturers have listed in the Food and Drug Administration’s (FDA) “Approved ...

In an unusual bipartisan effort, Senator Thom Tillis (R-N.C.) and Senator Chris Coons (D-Del.) have introduced a pair of bills that seek to strengthen US patents by limiting permissible challenges.

March 27, 2025 - Standard-essential patents (SEPs) are highly valued in any patent portfolio. To build a robust SEP portfolio, it is critical to follow practices that survive the Examiner's scrutiny ...

“In the wake of Amgen v. Sanofi, numerous excellent articles have explored how AI might help overcome the written description and enablement requirements facing biotechnology and life sciences patents ...